Hemab Therapeutics Holdings
COAG
#5019
Rank
A$2.71 B
Marketcap
A$58.08
Share price
0.01%
Change (1 day)
N/A
Change (1 year)

Hemab Therapeutics Holdings (COAG) - Cash on Hand

Cash on Hand as of June 2026 : A$0.68 Billion

According to Hemab Therapeutics Holdings's latest financial reports the company has A$0.68 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Hemab Therapeutics Holdings - Cash on Hand chart (from 2026 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$0.27 B95.02%
2024-12-31A$0.14 B